Literature DB >> 9658188

Phosphorylation and functional desensitization of the alpha2A-adrenergic receptor by protein kinase C.

M Liang1, M G Eason, E A Jewell-Motz, M A Williams, C T Theiss, G W Dorn, S B Liggett.   

Abstract

We have investigated the potential for protein kinase C (PKC) to phosphorylate and desensitize the alpha2A-adrenergic receptor (alpha2AAR). In whole-cell phosphorylation studies, recombinantly expressed human alpha2AAR displayed an increase in phosphorylation after short-term exposure to 100 nM phorbol 12-myristate-13-acetate (PMA) that was blocked by preincubation with a PKC inhibitor. This increase in receptor phosphorylation over basal amounted to 172 +/- 40% in COS-7 cells and 201 +/- 40% in Chinese hamster ovary cells. In permanently transfected Chinese hamster fibroblast cells, PKC activation by brief exposure of the cells to PMA resulted in a marked desensitization of alpha2AAR function, amounting to a 68 +/- 4% decrease in the maximal agonist (UK14304)-stimulated intracellular calcium release. Such desensitization was blocked by the PKC inhibitor bisindolylmaleimide I and was not evoked by an inactive phorbol ester. The desensitization of this agonist response was not caused by PKC-mediated augmentation of G protein-coupled receptor kinase activity, because PMA-promoted desensitization of a mutated alpha2AAR that lacked G protein-coupled receptor kinase phosphorylation sites was identical to that of wild-type alpha2AAR. To test whether PKC phosphorylation is a mechanism by which alpha2AAR can be regulated by other receptors, the alpha1bAR was co-expressed with the alpha2AAR in Chinese hamster ovary cells. Upon selective activation of alpha1bAR, the function of alpha2AAR underwent a 53 +/- 5% desensitization. Thus, cellular events that result in PKC activation promote phosphorylation of the alpha2AAR and lead to substantial desensitization of receptor function. This heterologous regulation also represents a mechanism by which rapid crosstalk between the alpha2AAR and other receptors can occur.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658188     DOI: 10.1124/mol.54.1.44

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

1.  Enhancement of noradrenaline release by angiotensin II and bradykinin in mouse atria: evidence for cross-talk between G(q/11) protein- and G(i/o) protein-coupled receptors.

Authors:  S L Cox; V Schelb; A U Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Regulation of alpha2AR trafficking and signaling by interacting proteins.

Authors:  Qin Wang; Lee E Limbird
Journal:  Biochem Pharmacol       Date:  2006-12-28       Impact factor: 5.858

3.  Altered adrenergic receptor signaling following traumatic brain injury contributes to working memory dysfunction.

Authors:  N Kobori; B Hu; P K Dash
Journal:  Neuroscience       Date:  2010-10-23       Impact factor: 3.590

4.  Agonist-promoted homologous desensitization of human airway smooth muscle bitter taste receptors.

Authors:  Kathryn S Robinett; Deepak A Deshpande; Molly M Malone; Stephen B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-03       Impact factor: 6.914

5.  Enhanced hypotensive, bradycardic, and hypnotic responses to alpha2-adrenergic agonists in spinophilin-null mice are accompanied by increased G protein coupling to the alpha2A-adrenergic receptor.

Authors:  R Lu; Y Chen; C Cottingham; N Peng; K Jiao; L E Limbird; J M Wyss; Q Wang
Journal:  Mol Pharmacol       Date:  2010-04-29       Impact factor: 4.436

Review 6.  Are the pharmacology and physiology of α₂ adrenoceptors determined by α₂-heteroreceptors and autoreceptors respectively?

Authors:  Ralf Gilsbach; Lutz Hein
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

7.  Effects of the noradrenergic system in rat white matter exposed to oxygen-glucose deprivation in vitro.

Authors:  Maria A Nikolaeva; Sandra Richard; Abdeslam Mouihate; Peter K Stys
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

8.  Potentiation of spinal alpha(2)-adrenoceptor analgesia in rats deficient in TRPV1-expressing afferent neurons.

Authors:  Shao-Rui Chen; Hao-Min Pan; Timothy E Richardson; Hui-Lin Pan
Journal:  Neuropharmacology       Date:  2007-03-24       Impact factor: 5.250

9.  Dynamic regulation of a GPCR-tetraspanin-G protein complex on intact cells: central role of CD81 in facilitating GPR56-Galpha q/11 association.

Authors:  Kevin D Little; Martin E Hemler; Christopher S Stipp
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

10.  Identification and characterization of distinct C-terminal domains of the human hydroxycarboxylic acid receptor-2 that are essential for receptor export, constitutive activity, desensitization, and internalization.

Authors:  Guo Li; Qi Zhou; Yena Yu; Linjie Chen; Ying Shi; Jiansong Luo; Jeffrey Benovic; Jianxin Lu; Naiming Zhou
Journal:  Mol Pharmacol       Date:  2012-09-07       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.